Evaluation of the Structure Modifying Effect of Avocado-Soybean Unsaponifiables in Hip Osteoarthritis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Study Classification

INTERVENTIONAL

Study Start Date

1999-12-31

Study Completion Date

2006-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to assess the long term (three years) ability of ASU (Avocado Soya unsaponifiable) to slow the decrease of radiographic JSW (Joint Space Width) in hip osteoarthritis (OA). This is a randomized, double blind, comparative, parallel group study versus placebo.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

TreatMent Of Knee osTeoarthritis wIth chONdroitin Sulfate - the OA MOTION Study

NCT05632783

Knee Osteoarthritis

WITHDRAWN PHASE3

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

NCT03793010

Osteoarthritis, Hip

TERMINATED PHASE3

Efficacy of Viscosupplementation Associated With Intra-articular Corticosteroid Injection Versus Intra-articular Injection of Corticosteroids Alone in Osteoarthritis of Hip

NCT02862639

Hip Osteoarthritis

COMPLETED PHASE3

Study Evaluating AGG-523 in Subjects With Osteoarthritis

NCT00427687

Osteoarthritis

COMPLETED PHASE1

Efficacy Evaluation of Hydrolyzed Collagen Peptide on Knees, Hips, and Ankle Pain in Osteoarthritis

NCT05369780

Pain, Joint

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Inclusion criteria:

Primary hip OA, fulfilling ACR criteria, patient over 45 y, painful \> 1 year, Lequesne's index \> or equal to 3, with minimum JSW at the target hip \> 1 mm and \< 4 mm on pelvic radiograph.

Primary criterion of efficacy:

The main criterion of efficacy is the change of JSW between baseline and end point. JSW is measured on the narrowest joint on pelvic or target hip X ray by blinded reader.

Randomisation is stratified according JSW at baseline (\< 2,5 mm or \> or equal to 2,5 mm).

Statistical analysis:

The Full Analysis Set (FAS) is defined by patients with at least one baseline value and one post baseline value.

The main analysis is scheduled on FAS using a Missing At Random (MAR)with a multiple model repeated measure (MMRM)to take in account missing value.

SAP (Statistical Analysis Plan) schedule to analyse JSW change as quantitative variable using an ANCOVA and as qualitative variable (progressors defined as JSW loss upper than 0,5 mm) using Mantel Haentzel test.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Osteoarthritis

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ASU (Avocado Soybean Unsaponifiable)

Group Type EXPERIMENTAL

ASU

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ASU

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* primary OA of hip,
* ACR criteria,
* older than 45 years,
* symptomatic painful \> 1 an,
* Lequesne's index \> or equal to 3,
* JSW between 1 and 4 mm on pelvic radiograph.